๐ฐ High Throughput Screening News
Page 7 - High Throughput Screening News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from High Throughput Screening. Real-time updates on events, politics, business and more.
August 26, 2022
The Global Cell Based Assays Market Report by TBRC covers cell based assays market size, drivers, restraints, key players, and the impact of COVID-19.
August 10, 2022
High-Throughput Screening Market Research Report by Product & Service (Consumables, Instruments, and Services), Technology, Application, End User, Region...
June 30, 2022
A research team from the LKS Faculty of Medicine, The University of Hong Kong discovered more efficient CRISPR-Cas9 variants that could be useful for gene therapy applications.
June 24, 2022
Scientists have described the development of a modified A549 cell line that shows a robust expression of ACE2 and TMPRSS2 and high susceptibility to SARS-CoV-2 infection.
June 23, 2022
The Business Research Companyโs Research Antibodies And Reagents Market 2022 - Opportunities And Strategies โ Global Forecast To 2030
June 22, 2022
/PRNewswire/ -- MedC Biopharma today announced a partnership with A2W Pharma of Malta in the development of MedCs proprietary novel cannabinoid formulations...
June 6, 2022
The Business Research Companyโs Research Antibodies And Reagents Global Market Report 2022 โ Market Size, Trends, And Global Forecast 2022-2026
May 18, 2022
Dublin, May 18, 2022 (GLOBE NEWSWIRE) -- The "Label Free Detection Market Forecast to 2028 - Global Analysis By Product, Technology, Application, and End...
May 12, 2022
In a recent study published in the journal Molecular Therapy, researchers identified Bifonazole, an imidazole-based antifungal agent, to have potent activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using high-throughput screening of small molecules.
May 5, 2022
/PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, today announced that...